August J. Troendle - 24 Apr 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Reporting relationship: CEO, Director, 10%+ Owner
Issuer ticker: MEDP
Reported as of: 24 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Apr 2026, 16:55:40 UTC
Prior SEC filing: 04 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle

Key filing fact

August J. Troendle filed Form 4 for Medpace Holdings, Inc. (MEDP) on 28 Apr 2026.

Key facts

This page summarizes August J. Troendle's Form 4 filing for Medpace Holdings, Inc. (MEDP).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 28 Apr 2026, 16:55.

Change

Previous filing in this sequence was filed on 04 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622058 Primary reporting owner

Troendle August J.

Relationship: CEO, Director, 10%+ Owner
Address: C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Signature date: 28 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 646,184
Date: 24 Apr 2026
Ownership: Direct

MEDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,733,019
Date: 24 Apr 2026
Ownership: By Medpace Investors, LLC
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +20,000
Change %
Price: $0.000000^*
Shares after: 20,000
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $410.54
Footnotes: F2

MEDP transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +10,000
Change %
Price: $0.000000^*
Shares after: 10,000
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F2

The option vests on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

Footnote F4

The restricted stock units vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.